Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Cipher Pharmaceuticals Inc
T.CPH
Alternate Symbol(s):
CPHRF
Healthcare
Cipher Pharmaceuticals Inc. is a specialty pharmaceutical company with a diversified portfolio of commercial and early to late-stage products, mainly in dermatology. The Company acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and markets those products in Canada, the United States, and South America. Its dermatology...
products include Actikerall, Epuris, and Vaniqa. Its hospital acute care products include Aggrastat and Brinavess. Its out-licensed products include Absorica, ConZip and Lipofen. Durela is its specialty medicine. Its product pipeline includes MOB-015, CF-101, and DTR-001. It delivers novel products to healthcare professionals and patients in Canada in a range of therapeutic areas, including dermatology, women’s health, urology and others. It also has the Natroba operations and global product rights to Natroba and its authorized generic Spinosad, a topical treatment for both head lice and scabies.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:CPH)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(9)
•••
drewmumaw
X
View Profile
View Bullboard History
Comment by
drewmumaw
on Jan 18, 2024 8:25pm
RE:New competitor to Epuris launches in Canada
This was discussed in the Q2 2023 call around the 26:00 minute mark.
(6026)
•••
retiredcf
X
View Profile
View Bullboard History
Post by
retiredcf
on Dec 29, 2023 9:34am
Keystone Financial
KeyStone’s Latest Small-Cap Growth Stock Recommendation: Cipher Pharmaceuticals (CPH:TSX) Recommended: August 28, 2023, at $3.89 Today's Price: $5.70 Gain: 46.5% Cipher (CPH
...more
Pharmaceutical Tech Co Reports 2.7X Revenue Growth Year-Over-Year at US $24 Million
posted Nov 21, 2024 9:00am by
Innocan Pharma Corp
-
|
"Our strong operational and financial momentum continued throughout 2024 and now in the third quarter, we again demonstrated solid financial results. We are pleased to report nine consecutive quarters of continuous revenue growth. Our online platform continues to perform exceptionally well, contributing to our strong nine-month revenue growth of 174% YoY ...read more
(6026)
•••
retiredcf
X
View Profile
View Bullboard History
Post by
retiredcf
on Dec 05, 2023 7:07am
Assessment
CPH has performed strongly year-to-date (up 63.5%) and particularly spiked up in the last month (+44%). The recent Q3 earnings were likely the reason for the rally. Revenue was up 26.6% to $6.1M and
...more
(2)
•••
Spuds69
X
View Profile
View Bullboard History
Post by
Spuds69
on Dec 04, 2023 4:29pm
New competitor to Epuris launches in Canada
FYI - Sun Pharma Canada Launches (PR)ABSORICA LD® (isotretinoin capsules) for Treatment of Severe Acne (yahoo.com) Unbelievable that this product has been approved since June 2023 and this
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Nov 24, 2023 5:00pm
New Press Release - Cipher Pharmaceuticals Announces Change of Auditor
MISSISSAUGA, ON, Nov. 24, 2023 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) ("Cipher" or "the Company") today announced that it has changed its auditors from Ernst & Young LLP ("Former Auditor") to RSM Canada LLP ("Successor Auditor") effective November 23, 2023. At the request of the Company...
read article.
(6026)
•••
retiredcf
X
View Profile
View Bullboard History
Post by
retiredcf
on Nov 22, 2023 8:07am
Ink Research
Today, we revisit two healthcare stocks, Knight Therapeutics (GUD), last featured here on June 9th, 2022, and Cipher Pharmaceuticals (CPH), last featured here on September 18th. Knight
...more
(3522)
•••
nozzpack
X
View Profile
View Bullboard History
Post by
nozzpack
on Nov 16, 2023 8:45am
Cipher to buyback 10% of the float
Cipher Pharma arranges NCIB to buy back up to 10% float 2023-11-15 17:08 ET - News Release An anonymous director reports CIPHER PHARMACEUTICALS ANNOUNCES NORMAL COURSE
...more
(3522)
•••
nozzpack
X
View Profile
View Bullboard History
Post by
nozzpack
on Nov 14, 2023 8:03am
Peer based Valuation Is $12
I use Biostent ( T.RX ) which is a very close sibling of CPH. Great balance sheet.....but not as good as as CPH. Similar drug suites...but not as good as CPH as RX shows no growth . RX trades at 20
...more
(3522)
•••
nozzpack
X
View Profile
View Bullboard History
Comment by
nozzpack
on Nov 10, 2023 10:35am
RE:Spectacular Earnings Numbers..Virtual Cash Cow
So, it's worth $2.25 per share on its cash alone and no debt. Over the past 3 quarters, it has been free cash flowing over $6 million cad per quarter. Thats about $25 million or $1 per share
...more
(3522)
•••
nozzpack
X
View Profile
View Bullboard History
Post by
nozzpack
on Nov 10, 2023 10:11am
Spectacular Earnings Numbers..Virtual Cash Cow
Cipher earns $7.03-million (U.S.) in Q3 2023 2023-11-09 17:33 ET - News Release Mr. Craig Mull reports CIPHER
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Oct 27, 2023 7:01am
New Press Release - Cipher Pharmaceuticals Schedules Q3 2023 Earnings Release and Conference Call
MISSISSAUGA, ON, Oct. 27, 2023 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) ("Cipher" or "the Company") today announced that it will release its financial results for the third quarter of 2023 on Thursday, November 9, 2023. The Company will also host a conference call on Friday, November 10...
read article.
(2126)
•••
lscfa
X
View Profile
View Bullboard History
Comment by
lscfa
on Oct 12, 2023 10:10am
RE:New Press Release - Cipher Pharmaceuticals Announces Final Results of Substantial Issuer Bid
Huge tax bill to shareholders who tendered.
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Oct 12, 2023 9:58am
New Press Release - Cipher Pharmaceuticals Announces Final Results of Substantial Issuer Bid
MISSISSAUGA, ON, Oct. 12, 2023/CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) ("Cipher" or the "Company"), today announced the final results of its substantial issuer bid (the "Offer"), which expired at 5:00 p.m. (Eastern Time) on October 11, 2023. The Company expects to take up and pay for 1,290...
read article.
(9)
•••
drewmumaw
X
View Profile
View Bullboard History
Post by
drewmumaw
on Oct 11, 2023 1:48pm
Enrollment complete for the 2nd North American Phase 3 study
According to this Swedish financial news outlet: https://www.redeye.se/research/946026/moberg-pharma-completed-enrollment-for-the-phase-3-study-in-the-us According to this
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Discover Options Trading Strategies to Minimize your Tax Burden